Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer

COVI3 study investigators

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)193-195
Number of pages3
JournalThe Lancet Oncology
Volume23
Issue number2
DOIs
StatePublished - Feb 2022

Cite this